Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
Xcel Brands Co-Founds ORME, a Next Generation Short-Form Video Marketplace
|
Xcel Brands (Nasdaq: XELB), a media and consumer products company with expertise in livestream shopping and social commerce, today announced its 30% investment in ORME, a groundbreaking short-form video (SFV) marketplace designed to revolutionize social commerce.
“ORME is an opportunity with unicorn potential,” said Robert W. D’Loren, Chairman and Chief Executive Officer of Xcel. “ORME is redefining how consumers interact with brands and products, creating a seamless and engaging shopping experience that provides a nearly infinite return on ad spend for brands and gives all shoppers an opportunity to participate in the retail commerce flywheel.”
For more information, visit www.xcelbrands.com
|
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
BullFrog AI (Nasdaq: BFRG), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD. “We are thrilled to welcome Dr. Smith and Dr. Wala to our advisory board,” said Vin Singh, CEO of BullFrog AI. “Their remarkable achievements and deep knowledge in their respective fields will be invaluable as we continue to push the boundaries of AI in biotechnology, and their insights will be instrumental in guiding our mission to develop breakthrough therapies and improve patient outcomes.”
|
Mobilicom’s ICE Cybersecurity Software Drone Solutions Purchased by Israel’s Ministry of Defense
Mobilicom (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today announced that its ICE Cybersecurity, the world’s first AI-based 360° software cybersecurity system for drones, has been chosen by Israel’s Ministry of Defense for its small-sized drone program. Mobilicom’s proven solutions, including its ICE Suite and SkyHopper Pro datalinks were purchased for immediate delivery. The initial order was fully delivered in January 2024. Additional orders and deliveries are expected in Q2 2024 and beyond. “Israel’s Ministry of Defense has thoroughly tested our ICE Cybersecurity software solution and validated its robust capabilities,” stated Mobilicom CEO and Founder Oren Elkayam.
|
|
|
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
60 Degrees Pharmaceuticals (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that, following a Type C meeting held on January 17, 2024 with the US Food and Drug Administration (FDA), the Company will move forward with a pivotal clinical study of tafenoquine in hospitalized babesiosis patients in the U.S. “We are excited to advance this important study,” said Geoff Dow, Chief Executive Officer of 60 Degrees Pharmaceuticals.
|
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
bioAffinity Technologies (Nasdaq: BFIA), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced that India’s Office of the Controller General of Patents, Designs and Trade Marks has issued a Certificate of Grant of Patent to bioAffinity subsidiary OncoSelect Therapeutics, LLC for its compositions and methods to treat cancer using chemotherapeutic agents conjugated to porphyrins, resulting in targeted delivery of the drugs. “We are committed to improving the outcome for cancer patients around the world, beginning with lung cancer, the deadliest cancer killer. Strong intellectual property protection for our innovative science benefits not only patients in need of treatment and their physicians, but also our research team and our shareholders as well,” bioAffinity Technologies’ President and CEO Maria Zannes said.
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| 11:00am Eastern |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies |
| 4:15pm Eastern |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
Archived Events |
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| Meeting Duration 20 minutes |
| SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. |
|
|
|
|
|
| NASDAQ: AREC - American Resources |
| Meeting Duration 62 minutes |
| American Resources Corp. is building one of the most unique growth platforms to strategically align old-world, legacy assets with a more modern economy. |
|
|
|
|
|
| NASDAQ: XELB - Xcel Brands |
| Meeting Duration 32 minutes |
| Xcel Brands is a media and consumer products company engaged in the design, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. |
|
|
Lesson of the Week
Learn why you should pay attention to insider buying.
|
|
|
MidSouth Week in Review
The yield on the 10-year Treasury bond rose to 4.17% vs. 3.50% earlier in the month.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2024 Redchip Companies, Inc. All rights reserved.
|
|
© 2024 Redchip Companies, Inc. All rights reserved
|
|
| |
|
|
